Thomas G Auchincloss Net Worth & Insider Trades

Thomas G Auchincloss - Director, Concert Pharmaceuticals, Inc

As of March 13, 2020

What is Thomas G Auchincloss's Net Worth?

The current estimated net worth of Concert Pharmaceuticals, Inc's Director, Thomas G Auchincloss, is estimated to be about $1.21M . Thomas G Auchincloss owns about 6,500 units of Concert Pharmaceuticals, Inc common stock. In the last 6 years at Concert Pharmaceuticals, Inc, Thomas G Auchincloss has sold an estimated value of $0 worth.

What is Thomas G Auchincloss's Past Insider Trading?

Thomas G Auchincloss's largest purchase order was 2,000 units , worth over $20.21K on May 16, 2016. In total, Thomas G Auchincloss has made about 8 transactions over 6 years of their time at Concert Pharmaceuticals, Inc. Thomas G Auchincloss usually trades in June, with the busiest year in 2020 and 2016. The most recent transaction was a purchase order of 1,500 units , worth over $12.77K on March 13, 2020.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Thomas G Auchincloss's' Mailing Address?

  • Mailing address is C/o Metabolix, Inc. 21 Erie Street Cambridge MA 02139 MA

Concert Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Stock Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Roger D. Tung 2020 $581,967 - $1,011,657 $1,098,957 $320,082 $12,114 $3,024,777
Roger D. Tung 2019 $562,287 - $1,889,500 - $309,258 $11,304 $2,772,349
James V. Cassella 2020 $450,633 - $283,144 $306,708 $225,317 $15,408 $1,281,210
James V. Cassella 2019 $435,394 - $708,563 $319,397 $217,697 $13,988 $1,695,039
Nancy Stuart 2020 $444,530 - $455,212 $493,096 $177,812 $12,114 $1,582,764
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1367920/000136792021000022/a2021proxy.htm

What are Concert Pharmaceuticals, Inc's Past Insider Trades?

Concert Pharmaceuticals, Inc's most recent insider trade came on June 6, 2022 by Christi Heek Van who bought 10,526 units worth $50K . In the last 8 years, insiders at Concert Pharmaceuticals, Inc have sold an estimated value of $71.76M and bought an estimated value of $26.81M worth of shares. Insider trading is most common in June, with the busiest year in 2018 and 2015. The most active traders at the company are Nancy Stuart, Chief Operating Officer,  Roger Tung, Chief Executive Officer,  and Richard Aldrich, Director .

CONCERT PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1